−25JPY
−812.41 MJPY
428.36 MJPY
25.01 M
About D.WESTERN THERAPEUTICS INST INC
Sector
Headquarters
Nagoya
Employees (FY)
21
Website
Founded
1999
ISIN
JP3548740004
FIGI
BBG000P8V2G8
D Western Therapeutics Institute, Inc is a Japan-based company engaged in the research and development of new pharmaceuticals. The Company generates revenue from licensing of its developed drugs to other companies. As of December 31, 2012, the Company’s drug pipeline included anti-thrombotic medicine K-134, therapeutic agent K-115 for glaucoma, and anticancer drug HMN-214. Its newly-developed products include new anti-thrombotic medicine and signal-transduction inhibitors, including therapeutic agent for high-blood pressure, protective agent for nerves, therapeutic agent for atherosclerosis, ophthalmologic drug and anticancer drug, among others. The Company is also developing new drug candidate compounds focusing on protein kinase inhibitors.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4576 is 113 JPY — it has decreased by 3.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange D.WESTERN THERAPEUTICS INST INC stocks are traded under the ticker 4576.
D.WESTERN THERAPEUTICS INST INC is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track D.WESTERN THERAPEUTICS INST INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, 4576 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade D.WESTERN THERAPEUTICS INST INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 21.00 employees. See our rating of the largest employees — is D.WESTERN THERAPEUTICS INST INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. D.WESTERN THERAPEUTICS INST INC EBITDA is −749.84 M JPY, and current EBITDA margin is −175.05%. See more stats in D.WESTERN THERAPEUTICS INST INC financial statements.